HIGHLIGHTS
- who: Tomohiro Umeda1 and collaborators from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, Osaka, Japan, Medilabo have published the research: Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination - A Preclinical Study in Model Mice, in the Journal: (JOURNAL)
- what: The authors propose five requirements of preventive medicines for neurodegenerative dementia. The authors hypothesize the main reason for these failures is the late timing of the medication.
SUMMARY
Resveratrol is a multifunctional agent that shows antioxidant, anti-inflammatory, anti-diabetes, anti-cancer, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.